Corbus Pharmaceuticals's total assets for Q4 2025 were $168.19M, an increase of 53.58% from the previous quarter. CRBP total liabilities were $20.69M for the fiscal quarter, a 19.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.